184 related articles for article (PubMed ID: 15114658)
21. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
Mangalam A; Rodriguez M; David C
Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
[TBL] [Abstract][Full Text] [Related]
22. Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma.
Furlan R; Bergami A; Cantarella D; Brambilla E; Taniguchi M; Dellabona P; Casorati G; Martino G
Eur J Immunol; 2003 Jul; 33(7):1830-8. PubMed ID: 12811843
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against a class II HLA-peptide complex raised by active immunization of mice with antigen mimicking peptides.
Dam-Tuxen R; Riise E
Scand J Immunol; 2009 Aug; 70(2):93-100. PubMed ID: 19630914
[TBL] [Abstract][Full Text] [Related]
24. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.
Irony-Tur-Sinai M; Grigoriadis N; Lourbopoulos A; Pinto-Maaravi F; Abramsky O; Brenner T
Exp Neurol; 2006 Mar; 198(1):136-44. PubMed ID: 16423348
[TBL] [Abstract][Full Text] [Related]
25. Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies.
Montero E; Nussbaum G; Kaye JF; Perez R; Lage A; Ben-Nun A; Cohen IR
J Autoimmun; 2004 Aug; 23(1):1-7. PubMed ID: 15236747
[TBL] [Abstract][Full Text] [Related]
26. CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice.
Mars LT; Bauer J; Gross DA; Bucciarelli F; Firat H; Hudrisier D; Lemonnier F; Kosmatopoulos K; Liblau RS
J Immunol; 2007 Oct; 179(8):5090-8. PubMed ID: 17911594
[TBL] [Abstract][Full Text] [Related]
27. Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice.
Smith PA; Heijmans N; Ouwerling B; Breij EC; Evans N; van Noort JM; Plomp AC; Delarasse C; 't Hart B; Pham-Dinh D; Amor S
Eur J Immunol; 2005 Apr; 35(4):1311-9. PubMed ID: 15761848
[TBL] [Abstract][Full Text] [Related]
28. OSP/claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179-207.
Kaushansky N; Hemo R; Eisenstein M; Ben-Nun A
Eur J Immunol; 2007 Jul; 37(7):2018-31. PubMed ID: 17549734
[TBL] [Abstract][Full Text] [Related]
29. A viral peptide with limited homology to a self peptide can induce clinical signs of experimental autoimmune encephalomyelitis.
Gautam AM; Liblau R; Chelvanayagam G; Steinman L; Boston T
J Immunol; 1998 Jul; 161(1):60-4. PubMed ID: 9647207
[TBL] [Abstract][Full Text] [Related]
30. Treatment of autoimmune diseases through manipulation of antigen presentation.
Spack EG
Crit Rev Immunol; 1997; 17(5-6):529-36. PubMed ID: 9419440
[TBL] [Abstract][Full Text] [Related]
31. Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor.
Moisini I; Nguyen P; Fugger L; Geiger TL
J Immunol; 2008 Mar; 180(5):3601-11. PubMed ID: 18292588
[TBL] [Abstract][Full Text] [Related]
32. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice.
Oliver AR; Lyon GM; Ruddle NH
J Immunol; 2003 Jul; 171(1):462-8. PubMed ID: 12817031
[TBL] [Abstract][Full Text] [Related]
33. Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells.
Illés Z; Stern JN; Reddy J; Waldner H; Mycko MP; Brosnan CF; Ellmerich S; Altmann DM; Santambrogio L; Strominger JL; Kuchroo VK
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11749-54. PubMed ID: 15292513
[TBL] [Abstract][Full Text] [Related]
34. Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis.
Fridkis-Hareli M; Santambrogio L; Stern JN; Fugger L; Brosnan C; Strominger JL
J Clin Invest; 2002 Jun; 109(12):1635-43. PubMed ID: 12070311
[TBL] [Abstract][Full Text] [Related]
35. Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.
Jones MV; Nguyen TT; Deboy CA; Griffin JW; Whartenby KA; Kerr DA; Calabresi PA
J Neuroimmunol; 2008 Aug; 199(1-2):83-93. PubMed ID: 18582952
[TBL] [Abstract][Full Text] [Related]
36. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
[TBL] [Abstract][Full Text] [Related]
37. CDR3 sequence preference of TCRBV8S2+ T cells within the CNS does not reflect single amino acid dependent avidity expansion.
de Graaf KL; Berne GP; Herrmann MM; Hansson GK; Olsson T; Weissert R
J Neuroimmunol; 2005 Sep; 166(1-2):47-54. PubMed ID: 15963573
[TBL] [Abstract][Full Text] [Related]
38. Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4.
Nalawade SA; Ji N; Raphael I; Pratt A; Kraig E; Forsthuber TG
Cell Immunol; 2018 Sep; 331():38-48. PubMed ID: 29789121
[TBL] [Abstract][Full Text] [Related]
39. TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes.
Dahan R; Tabul M; Chou YK; Meza-Romero R; Andrew S; Ferro AJ; Burrows GG; Offner H; Vandenbark AA; Reiter Y
Eur J Immunol; 2011 May; 41(5):1465-79. PubMed ID: 21469129
[TBL] [Abstract][Full Text] [Related]
40. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
